MarketInOut Stock Screener Log In | Sign Up

Biofrontera Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/06/2026
Biofrontera Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12.3 mln
Float12.84 mln
Earnings Date11/18/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

2.08
Highly suspicious

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

1.26
Elevated leverage

Pre-Tax Margin

-14%
Loss-making

ROE

-209
Deeply negative

Business Description

Biofrontera is a US-based company focused on bringing specialized skin care treatments to market. Its main product, Ameluz, is used alongside a proprietary lamp system to treat actinic keratosis, a condition where sun-damaged skin develops lesions that can become cancerous if left untreated. Founded in 2015 and operating out of Woburn, Massachusetts, the company works to make these treatments available to patients across the country.

Key Fundamentals

EPS-0.43
ROE-209
RPS3.92
ROIC-10.89
ROA-28.17
Interest Cover-18.81
EBITDA, mln-5.04
EV / EBITDA-2.80
EV / EBIT-2.41
Revenue, mln46.17
EV / Revenue0.31

Quote Details

Last 0.828
Change 0.0202 (2.5%)
Open 0.82
Volume 208,051
Turnover 172,266
Average Volume 173,517

Financial Ratios

Pre-Tax Profit Margin-14
Leverage Ratio4.04
Current Ratio1.18
Price / Book2.00
Price / Tangible Book3.53
Debt / Equity1.26
Price / Sales0.21

Financial Strength

Altman Z-Score-6.13
Piotroski F-Score 4 / 9
Beneish M-Score2.08
Short Ratio0.25
Short % of Float0.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.14% 27 / 100   
1 Month -9.88% 33 / 100   
2 Months -30.42% 18 / 100   
6 Months -28% 24 / 100   
1 Year -24.04% 28 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog